Purchase 2C-C, 2C-E, 2C-I, 2C-P, 2C-H
With us securely! - re-shipment guarantees.
We always offer new legal products of impeccable quality.
Please make sure that the product is legal in your country and not under control before ordering.
We do not sell pharmaceutical products or controlled products.
Where to buy 2C-C, 2C-E, 2C-I, 2C-P, 2C-H for sale
Psychedelics have long been of tremendous interest, especially to individuals seeking to expand their minds and gain fresh perspectives on the world. This is shown by the 2C family of psychedelics created by Alexander Shulgin. Shulgin is a renowned scientist and psychopharmacologist who has devoted his life to investigating the impact of various substances on the human mind and body. This essay will explore the universe of 2C-C, 2C-E, and 2C-I, three of the most popular psychedelics in the 2C family, and what makes them so distinctive.
Introduction to Alexander Shulgin and the 2C Family
Alexander Shulgin commonly referred to as "the Godfather of Psychedelics," was a man who lived ahead of his time. Shulgin, born on June 25, 1925, devoted most of his life to investigating the effects of different substances on the human mind and body. His results were described in the book PiHKAL (Phenethylamines I Have Known and Loved), which remains an invaluable reference for anybody interested in psychedelics. The 2C psychedelic family is one of his most notable contributions to the psychedelic field.
2C-C: A Psychedelic Experience
2C-C is a psychedelic substance that belongs to the 2C psychedelics family. Shulgin suggests a dose range of 20–40 mg, which is often used orally but may also be insufflated. The Controlled Substances Act classifies it as a Schedule I drug in the United States.
The effects of 2C-C are well-documented, with users claiming heightened visual and aural experiences and deep mental shifts. This can result in exhilaration and a sensation of oneness with the surrounding world. Typically, the effects of 2C-C are felt after 45 minutes of administration and can continue for up to six hours.
2C-E: The Sensory Experience
Another prominent member of the 2C family is 2C-E. Similar to 2C-C, it was initially synthesized by Alexander Shulgin, who chronicled the process in his book PiHKAL. The suggested dose range for 2C-E is 10 to 25 mg.
Users of 2C-E have reported comparable effects to LSD, including heightened sensory awareness, intensified visual and aural hallucinations, and dramatic alterations in cognitive processes. The effects of 2C-E can last up to eight hours and normally take 45 minutes to an hour to manifest.
2C-I: The Mental Adventure
Another prominent member of the 2C family is 2C-I. Alexander Shulgin initially synthesized it and discussed it in his 1991 book PiHKAL. The suggested dose range for 2C-I is 10 to 25 mg.
It is known that the effects of 2C-I are comparable to those of LSD and mescaline, with users experiencing substantial alterations in thinking processes, heightened visual and aural hallucinations, and a sensation of euphoria. The effects of 2C-I can last up to eight hours and normally take 45 minutes to an hour to manifest.
To prepare the content, the following materials were used:
- FDA Substance Registration System
- Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
- Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
- Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
- An overview of alcohol and other drug issues
- Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
- The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
- Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I
- Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
- Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
- Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
- Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug Scheduling
- Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
- Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
- Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
- FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
- Controlled Substances Act
- The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics
-min-200x127.JPG)
